about
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer.Genetics and prevention of pancreatic cancer.Expression of truncated bile salt-dependent lipase variant in pancreatic pre-neoplastic lesions.New and potential clinical applications of KRAS as a cancer biomarker.
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Molecular diagnosis of pancreas carcinoma.
@en
type
label
Molecular diagnosis of pancreas carcinoma.
@en
prefLabel
Molecular diagnosis of pancreas carcinoma.
@en
P2860
P1476
Molecular diagnosis of pancreas carcinoma
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2825(1997)11:4<225::AID-JCLA9>3.0.CO;2-7
P577
1997-01-01T00:00:00Z